Corporate News

2024

Director/PDMR Shareholding

04 August 2022

Non-Executive Chairman buys 1m shares

MyHealthChecked plc (AIM:MHC), the consumer home-testing healthcare company,  announces that it was notified that on 3 August 2022 Adam Reynolds, Non-Executive Chairman, purchased a total of 1,000,000 (one million) ordinary shares of 0.1 pence each in the Company ("Ordinary Shares") at a price of 1.7 pence per Ordinary Share.

Following this transaction, Adam Reynolds' total direct and indirect interest in the Company is 10,513,293 Ordinary Shares representing approximately 1.35% of the Group's total issued share capital.

The Notification of Dealing Form required in accordance with UK MAR is set out below.

 

For further information contact:

MyHealthChecked plc

www.myhealthchecked.com

Penny McCormick, Chief Executive Officer

via Walbrook PR



SPARK Advisory Partners Limited (NOMAD)

Tel: +44 (0)20 3368 3550

Neil Baldwin




Oberon Capital Ltd (Broker)

Tel: +44 (0)20 3179 5344

Mike Seabrook

[email protected]



Walbrook PR Ltd (Media & IR)

Tel: +44 (0)20 7933 8780 or [email protected]

Paul McManus / Alice Woodings

Mob: +44 (0)7980 541 893 / +44 (0)7407 804 654

 

 

About MyHealthChecked PLC ( www.myhealthcheckedplc.com )

MyHealthChecked PLC, based in Cardiff, is an AIM-quoted pioneering UK healthcare company focused on a range of at-home healthcare and wellness tests.

MyHealthChecked is the umbrella brand of a range of at-home DNA and RNA tests that have been developed following the acquisition of The Genome Store in November 2020. The tests are available online, and in some cases, for over-the-counter purchase.

The MyHealthChecked portfolio has been identified as part of a change in mindset as customers become more familiar with the concept of accessible healthcare in the growing at home testing kit market with a focus on accessibility at the right price, led by UK-based experts.

Notification and public disclosure of transactions by persons discharging managerial responsibilities ("PDMRs") and persons closely associated ("PCA") with them.

 

1

Details of the person discharging managerial responsibilities / person closely associated

a)

Name

Adam Reynolds

2

Reason for the notification

a)

Position/status

Non-Executive Chairman

b)

Initial notification /Amendment

Initial Notification

3

Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor

a)

Name

MYHEALTHCHECKED plc

b)

LEI

213800RBHY6LZDG13168

4

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

a)

 

Description of the financial instrument, type of instrument

Ordinary Shares



Identification code

ISIN: GB00BYZ2R301



b)

Nature of the transaction

Purchase of Ordinary Shares

c)

 

Price(s) and volume(s)






Price(s)

Volume(s)




1.7 pence

1,000,000






d)

 

Aggregated information




- Aggregated volume

N/A - Single Transaction



- Price




e)

Date of the transaction

3 August 2022

f)

Place of the transaction

London Stock Exchange - AIMX

2023

Director/PDMR Shareholding

04 August 2022

Non-Executive Chairman buys 1m shares

MyHealthChecked plc (AIM:MHC), the consumer home-testing healthcare company,  announces that it was notified that on 3 August 2022 Adam Reynolds, Non-Executive Chairman, purchased a total of 1,000,000 (one million) ordinary shares of 0.1 pence each in the Company ("Ordinary Shares") at a price of 1.7 pence per Ordinary Share.

Following this transaction, Adam Reynolds' total direct and indirect interest in the Company is 10,513,293 Ordinary Shares representing approximately 1.35% of the Group's total issued share capital.

The Notification of Dealing Form required in accordance with UK MAR is set out below.

 

For further information contact:

MyHealthChecked plc

www.myhealthchecked.com

Penny McCormick, Chief Executive Officer

via Walbrook PR



SPARK Advisory Partners Limited (NOMAD)

Tel: +44 (0)20 3368 3550

Neil Baldwin




Oberon Capital Ltd (Broker)

Tel: +44 (0)20 3179 5344

Mike Seabrook

[email protected]



Walbrook PR Ltd (Media & IR)

Tel: +44 (0)20 7933 8780 or [email protected]

Paul McManus / Alice Woodings

Mob: +44 (0)7980 541 893 / +44 (0)7407 804 654

 

 

About MyHealthChecked PLC ( www.myhealthcheckedplc.com )

MyHealthChecked PLC, based in Cardiff, is an AIM-quoted pioneering UK healthcare company focused on a range of at-home healthcare and wellness tests.

MyHealthChecked is the umbrella brand of a range of at-home DNA and RNA tests that have been developed following the acquisition of The Genome Store in November 2020. The tests are available online, and in some cases, for over-the-counter purchase.

The MyHealthChecked portfolio has been identified as part of a change in mindset as customers become more familiar with the concept of accessible healthcare in the growing at home testing kit market with a focus on accessibility at the right price, led by UK-based experts.

Notification and public disclosure of transactions by persons discharging managerial responsibilities ("PDMRs") and persons closely associated ("PCA") with them.

 

1

Details of the person discharging managerial responsibilities / person closely associated

a)

Name

Adam Reynolds

2

Reason for the notification

a)

Position/status

Non-Executive Chairman

b)

Initial notification /Amendment

Initial Notification

3

Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor

a)

Name

MYHEALTHCHECKED plc

b)

LEI

213800RBHY6LZDG13168

4

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

a)

 

Description of the financial instrument, type of instrument

Ordinary Shares



Identification code

ISIN: GB00BYZ2R301



b)

Nature of the transaction

Purchase of Ordinary Shares

c)

 

Price(s) and volume(s)






Price(s)

Volume(s)




1.7 pence

1,000,000






d)

 

Aggregated information




- Aggregated volume

N/A - Single Transaction



- Price




e)

Date of the transaction

3 August 2022

f)

Place of the transaction

London Stock Exchange - AIMX

2022

Director/PDMR Shareholding

04 August 2022

Non-Executive Chairman buys 1m shares

MyHealthChecked plc (AIM:MHC), the consumer home-testing healthcare company,  announces that it was notified that on 3 August 2022 Adam Reynolds, Non-Executive Chairman, purchased a total of 1,000,000 (one million) ordinary shares of 0.1 pence each in the Company ("Ordinary Shares") at a price of 1.7 pence per Ordinary Share.

Following this transaction, Adam Reynolds' total direct and indirect interest in the Company is 10,513,293 Ordinary Shares representing approximately 1.35% of the Group's total issued share capital.

The Notification of Dealing Form required in accordance with UK MAR is set out below.

 

For further information contact:

MyHealthChecked plc

www.myhealthchecked.com

Penny McCormick, Chief Executive Officer

via Walbrook PR



SPARK Advisory Partners Limited (NOMAD)

Tel: +44 (0)20 3368 3550

Neil Baldwin




Oberon Capital Ltd (Broker)

Tel: +44 (0)20 3179 5344

Mike Seabrook

[email protected]



Walbrook PR Ltd (Media & IR)

Tel: +44 (0)20 7933 8780 or [email protected]

Paul McManus / Alice Woodings

Mob: +44 (0)7980 541 893 / +44 (0)7407 804 654

 

 

About MyHealthChecked PLC ( www.myhealthcheckedplc.com )

MyHealthChecked PLC, based in Cardiff, is an AIM-quoted pioneering UK healthcare company focused on a range of at-home healthcare and wellness tests.

MyHealthChecked is the umbrella brand of a range of at-home DNA and RNA tests that have been developed following the acquisition of The Genome Store in November 2020. The tests are available online, and in some cases, for over-the-counter purchase.

The MyHealthChecked portfolio has been identified as part of a change in mindset as customers become more familiar with the concept of accessible healthcare in the growing at home testing kit market with a focus on accessibility at the right price, led by UK-based experts.

Notification and public disclosure of transactions by persons discharging managerial responsibilities ("PDMRs") and persons closely associated ("PCA") with them.

 

1

Details of the person discharging managerial responsibilities / person closely associated

a)

Name

Adam Reynolds

2

Reason for the notification

a)

Position/status

Non-Executive Chairman

b)

Initial notification /Amendment

Initial Notification

3

Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor

a)

Name

MYHEALTHCHECKED plc

b)

LEI

213800RBHY6LZDG13168

4

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

a)

 

Description of the financial instrument, type of instrument

Ordinary Shares



Identification code

ISIN: GB00BYZ2R301



b)

Nature of the transaction

Purchase of Ordinary Shares

c)

 

Price(s) and volume(s)






Price(s)

Volume(s)




1.7 pence

1,000,000






d)

 

Aggregated information




- Aggregated volume

N/A - Single Transaction



- Price




e)

Date of the transaction

3 August 2022

f)

Place of the transaction

London Stock Exchange - AIMX

2021

Director/PDMR Shareholding

04 August 2022

Non-Executive Chairman buys 1m shares

MyHealthChecked plc (AIM:MHC), the consumer home-testing healthcare company,  announces that it was notified that on 3 August 2022 Adam Reynolds, Non-Executive Chairman, purchased a total of 1,000,000 (one million) ordinary shares of 0.1 pence each in the Company ("Ordinary Shares") at a price of 1.7 pence per Ordinary Share.

Following this transaction, Adam Reynolds' total direct and indirect interest in the Company is 10,513,293 Ordinary Shares representing approximately 1.35% of the Group's total issued share capital.

The Notification of Dealing Form required in accordance with UK MAR is set out below.

 

For further information contact:

MyHealthChecked plc

www.myhealthchecked.com

Penny McCormick, Chief Executive Officer

via Walbrook PR



SPARK Advisory Partners Limited (NOMAD)

Tel: +44 (0)20 3368 3550

Neil Baldwin




Oberon Capital Ltd (Broker)

Tel: +44 (0)20 3179 5344

Mike Seabrook

[email protected]



Walbrook PR Ltd (Media & IR)

Tel: +44 (0)20 7933 8780 or [email protected]

Paul McManus / Alice Woodings

Mob: +44 (0)7980 541 893 / +44 (0)7407 804 654

 

 

About MyHealthChecked PLC ( www.myhealthcheckedplc.com )

MyHealthChecked PLC, based in Cardiff, is an AIM-quoted pioneering UK healthcare company focused on a range of at-home healthcare and wellness tests.

MyHealthChecked is the umbrella brand of a range of at-home DNA and RNA tests that have been developed following the acquisition of The Genome Store in November 2020. The tests are available online, and in some cases, for over-the-counter purchase.

The MyHealthChecked portfolio has been identified as part of a change in mindset as customers become more familiar with the concept of accessible healthcare in the growing at home testing kit market with a focus on accessibility at the right price, led by UK-based experts.

Notification and public disclosure of transactions by persons discharging managerial responsibilities ("PDMRs") and persons closely associated ("PCA") with them.

 

1

Details of the person discharging managerial responsibilities / person closely associated

a)

Name

Adam Reynolds

2

Reason for the notification

a)

Position/status

Non-Executive Chairman

b)

Initial notification /Amendment

Initial Notification

3

Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor

a)

Name

MYHEALTHCHECKED plc

b)

LEI

213800RBHY6LZDG13168

4

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

a)

 

Description of the financial instrument, type of instrument

Ordinary Shares



Identification code

ISIN: GB00BYZ2R301



b)

Nature of the transaction

Purchase of Ordinary Shares

c)

 

Price(s) and volume(s)






Price(s)

Volume(s)




1.7 pence

1,000,000






d)

 

Aggregated information




- Aggregated volume

N/A - Single Transaction



- Price




e)

Date of the transaction

3 August 2022

f)

Place of the transaction

London Stock Exchange - AIMX

2020

Director/PDMR Shareholding

04 August 2022

Non-Executive Chairman buys 1m shares

MyHealthChecked plc (AIM:MHC), the consumer home-testing healthcare company,  announces that it was notified that on 3 August 2022 Adam Reynolds, Non-Executive Chairman, purchased a total of 1,000,000 (one million) ordinary shares of 0.1 pence each in the Company ("Ordinary Shares") at a price of 1.7 pence per Ordinary Share.

Following this transaction, Adam Reynolds' total direct and indirect interest in the Company is 10,513,293 Ordinary Shares representing approximately 1.35% of the Group's total issued share capital.

The Notification of Dealing Form required in accordance with UK MAR is set out below.

 

For further information contact:

MyHealthChecked plc

www.myhealthchecked.com

Penny McCormick, Chief Executive Officer

via Walbrook PR



SPARK Advisory Partners Limited (NOMAD)

Tel: +44 (0)20 3368 3550

Neil Baldwin




Oberon Capital Ltd (Broker)

Tel: +44 (0)20 3179 5344

Mike Seabrook

[email protected]



Walbrook PR Ltd (Media & IR)

Tel: +44 (0)20 7933 8780 or [email protected]

Paul McManus / Alice Woodings

Mob: +44 (0)7980 541 893 / +44 (0)7407 804 654

 

 

About MyHealthChecked PLC ( www.myhealthcheckedplc.com )

MyHealthChecked PLC, based in Cardiff, is an AIM-quoted pioneering UK healthcare company focused on a range of at-home healthcare and wellness tests.

MyHealthChecked is the umbrella brand of a range of at-home DNA and RNA tests that have been developed following the acquisition of The Genome Store in November 2020. The tests are available online, and in some cases, for over-the-counter purchase.

The MyHealthChecked portfolio has been identified as part of a change in mindset as customers become more familiar with the concept of accessible healthcare in the growing at home testing kit market with a focus on accessibility at the right price, led by UK-based experts.

Notification and public disclosure of transactions by persons discharging managerial responsibilities ("PDMRs") and persons closely associated ("PCA") with them.

 

1

Details of the person discharging managerial responsibilities / person closely associated

a)

Name

Adam Reynolds

2

Reason for the notification

a)

Position/status

Non-Executive Chairman

b)

Initial notification /Amendment

Initial Notification

3

Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor

a)

Name

MYHEALTHCHECKED plc

b)

LEI

213800RBHY6LZDG13168

4

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

a)

 

Description of the financial instrument, type of instrument

Ordinary Shares



Identification code

ISIN: GB00BYZ2R301



b)

Nature of the transaction

Purchase of Ordinary Shares

c)

 

Price(s) and volume(s)






Price(s)

Volume(s)




1.7 pence

1,000,000






d)

 

Aggregated information




- Aggregated volume

N/A - Single Transaction



- Price




e)

Date of the transaction

3 August 2022

f)

Place of the transaction

London Stock Exchange - AIMX

2019

Director/PDMR Shareholding

04 August 2022

Non-Executive Chairman buys 1m shares

MyHealthChecked plc (AIM:MHC), the consumer home-testing healthcare company,  announces that it was notified that on 3 August 2022 Adam Reynolds, Non-Executive Chairman, purchased a total of 1,000,000 (one million) ordinary shares of 0.1 pence each in the Company ("Ordinary Shares") at a price of 1.7 pence per Ordinary Share.

Following this transaction, Adam Reynolds' total direct and indirect interest in the Company is 10,513,293 Ordinary Shares representing approximately 1.35% of the Group's total issued share capital.

The Notification of Dealing Form required in accordance with UK MAR is set out below.

 

For further information contact:

MyHealthChecked plc

www.myhealthchecked.com

Penny McCormick, Chief Executive Officer

via Walbrook PR



SPARK Advisory Partners Limited (NOMAD)

Tel: +44 (0)20 3368 3550

Neil Baldwin




Oberon Capital Ltd (Broker)

Tel: +44 (0)20 3179 5344

Mike Seabrook

[email protected]



Walbrook PR Ltd (Media & IR)

Tel: +44 (0)20 7933 8780 or [email protected]

Paul McManus / Alice Woodings

Mob: +44 (0)7980 541 893 / +44 (0)7407 804 654

 

 

About MyHealthChecked PLC ( www.myhealthcheckedplc.com )

MyHealthChecked PLC, based in Cardiff, is an AIM-quoted pioneering UK healthcare company focused on a range of at-home healthcare and wellness tests.

MyHealthChecked is the umbrella brand of a range of at-home DNA and RNA tests that have been developed following the acquisition of The Genome Store in November 2020. The tests are available online, and in some cases, for over-the-counter purchase.

The MyHealthChecked portfolio has been identified as part of a change in mindset as customers become more familiar with the concept of accessible healthcare in the growing at home testing kit market with a focus on accessibility at the right price, led by UK-based experts.

Notification and public disclosure of transactions by persons discharging managerial responsibilities ("PDMRs") and persons closely associated ("PCA") with them.

 

1

Details of the person discharging managerial responsibilities / person closely associated

a)

Name

Adam Reynolds

2

Reason for the notification

a)

Position/status

Non-Executive Chairman

b)

Initial notification /Amendment

Initial Notification

3

Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor

a)

Name

MYHEALTHCHECKED plc

b)

LEI

213800RBHY6LZDG13168

4

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

a)

 

Description of the financial instrument, type of instrument

Ordinary Shares



Identification code

ISIN: GB00BYZ2R301



b)

Nature of the transaction

Purchase of Ordinary Shares

c)

 

Price(s) and volume(s)






Price(s)

Volume(s)




1.7 pence

1,000,000






d)

 

Aggregated information




- Aggregated volume

N/A - Single Transaction



- Price




e)

Date of the transaction

3 August 2022

f)

Place of the transaction

London Stock Exchange - AIMX

2018

Director/PDMR Shareholding

04 August 2022

Non-Executive Chairman buys 1m shares

MyHealthChecked plc (AIM:MHC), the consumer home-testing healthcare company,  announces that it was notified that on 3 August 2022 Adam Reynolds, Non-Executive Chairman, purchased a total of 1,000,000 (one million) ordinary shares of 0.1 pence each in the Company ("Ordinary Shares") at a price of 1.7 pence per Ordinary Share.

Following this transaction, Adam Reynolds' total direct and indirect interest in the Company is 10,513,293 Ordinary Shares representing approximately 1.35% of the Group's total issued share capital.

The Notification of Dealing Form required in accordance with UK MAR is set out below.

 

For further information contact:

MyHealthChecked plc

www.myhealthchecked.com

Penny McCormick, Chief Executive Officer

via Walbrook PR



SPARK Advisory Partners Limited (NOMAD)

Tel: +44 (0)20 3368 3550

Neil Baldwin




Oberon Capital Ltd (Broker)

Tel: +44 (0)20 3179 5344

Mike Seabrook

[email protected]



Walbrook PR Ltd (Media & IR)

Tel: +44 (0)20 7933 8780 or [email protected]

Paul McManus / Alice Woodings

Mob: +44 (0)7980 541 893 / +44 (0)7407 804 654

 

 

About MyHealthChecked PLC ( www.myhealthcheckedplc.com )

MyHealthChecked PLC, based in Cardiff, is an AIM-quoted pioneering UK healthcare company focused on a range of at-home healthcare and wellness tests.

MyHealthChecked is the umbrella brand of a range of at-home DNA and RNA tests that have been developed following the acquisition of The Genome Store in November 2020. The tests are available online, and in some cases, for over-the-counter purchase.

The MyHealthChecked portfolio has been identified as part of a change in mindset as customers become more familiar with the concept of accessible healthcare in the growing at home testing kit market with a focus on accessibility at the right price, led by UK-based experts.

Notification and public disclosure of transactions by persons discharging managerial responsibilities ("PDMRs") and persons closely associated ("PCA") with them.

 

1

Details of the person discharging managerial responsibilities / person closely associated

a)

Name

Adam Reynolds

2

Reason for the notification

a)

Position/status

Non-Executive Chairman

b)

Initial notification /Amendment

Initial Notification

3

Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor

a)

Name

MYHEALTHCHECKED plc

b)

LEI

213800RBHY6LZDG13168

4

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

a)

 

Description of the financial instrument, type of instrument

Ordinary Shares



Identification code

ISIN: GB00BYZ2R301



b)

Nature of the transaction

Purchase of Ordinary Shares

c)

 

Price(s) and volume(s)






Price(s)

Volume(s)




1.7 pence

1,000,000






d)

 

Aggregated information




- Aggregated volume

N/A - Single Transaction



- Price




e)

Date of the transaction

3 August 2022

f)

Place of the transaction

London Stock Exchange - AIMX

2017

Director/PDMR Shareholding

04 August 2022

Non-Executive Chairman buys 1m shares

MyHealthChecked plc (AIM:MHC), the consumer home-testing healthcare company,  announces that it was notified that on 3 August 2022 Adam Reynolds, Non-Executive Chairman, purchased a total of 1,000,000 (one million) ordinary shares of 0.1 pence each in the Company ("Ordinary Shares") at a price of 1.7 pence per Ordinary Share.

Following this transaction, Adam Reynolds' total direct and indirect interest in the Company is 10,513,293 Ordinary Shares representing approximately 1.35% of the Group's total issued share capital.

The Notification of Dealing Form required in accordance with UK MAR is set out below.

 

For further information contact:

MyHealthChecked plc

www.myhealthchecked.com

Penny McCormick, Chief Executive Officer

via Walbrook PR



SPARK Advisory Partners Limited (NOMAD)

Tel: +44 (0)20 3368 3550

Neil Baldwin




Oberon Capital Ltd (Broker)

Tel: +44 (0)20 3179 5344

Mike Seabrook

[email protected]



Walbrook PR Ltd (Media & IR)

Tel: +44 (0)20 7933 8780 or [email protected]

Paul McManus / Alice Woodings

Mob: +44 (0)7980 541 893 / +44 (0)7407 804 654

 

 

About MyHealthChecked PLC ( www.myhealthcheckedplc.com )

MyHealthChecked PLC, based in Cardiff, is an AIM-quoted pioneering UK healthcare company focused on a range of at-home healthcare and wellness tests.

MyHealthChecked is the umbrella brand of a range of at-home DNA and RNA tests that have been developed following the acquisition of The Genome Store in November 2020. The tests are available online, and in some cases, for over-the-counter purchase.

The MyHealthChecked portfolio has been identified as part of a change in mindset as customers become more familiar with the concept of accessible healthcare in the growing at home testing kit market with a focus on accessibility at the right price, led by UK-based experts.

Notification and public disclosure of transactions by persons discharging managerial responsibilities ("PDMRs") and persons closely associated ("PCA") with them.

 

1

Details of the person discharging managerial responsibilities / person closely associated

a)

Name

Adam Reynolds

2

Reason for the notification

a)

Position/status

Non-Executive Chairman

b)

Initial notification /Amendment

Initial Notification

3

Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor

a)

Name

MYHEALTHCHECKED plc

b)

LEI

213800RBHY6LZDG13168

4

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

a)

 

Description of the financial instrument, type of instrument

Ordinary Shares



Identification code

ISIN: GB00BYZ2R301



b)

Nature of the transaction

Purchase of Ordinary Shares

c)

 

Price(s) and volume(s)






Price(s)

Volume(s)




1.7 pence

1,000,000






d)

 

Aggregated information




- Aggregated volume

N/A - Single Transaction



- Price




e)

Date of the transaction

3 August 2022

f)

Place of the transaction

London Stock Exchange - AIMX

2016

Director/PDMR Shareholding

04 August 2022

Non-Executive Chairman buys 1m shares

MyHealthChecked plc (AIM:MHC), the consumer home-testing healthcare company,  announces that it was notified that on 3 August 2022 Adam Reynolds, Non-Executive Chairman, purchased a total of 1,000,000 (one million) ordinary shares of 0.1 pence each in the Company ("Ordinary Shares") at a price of 1.7 pence per Ordinary Share.

Following this transaction, Adam Reynolds' total direct and indirect interest in the Company is 10,513,293 Ordinary Shares representing approximately 1.35% of the Group's total issued share capital.

The Notification of Dealing Form required in accordance with UK MAR is set out below.

 

For further information contact:

MyHealthChecked plc

www.myhealthchecked.com

Penny McCormick, Chief Executive Officer

via Walbrook PR



SPARK Advisory Partners Limited (NOMAD)

Tel: +44 (0)20 3368 3550

Neil Baldwin




Oberon Capital Ltd (Broker)

Tel: +44 (0)20 3179 5344

Mike Seabrook

[email protected]



Walbrook PR Ltd (Media & IR)

Tel: +44 (0)20 7933 8780 or [email protected]

Paul McManus / Alice Woodings

Mob: +44 (0)7980 541 893 / +44 (0)7407 804 654

 

 

About MyHealthChecked PLC ( www.myhealthcheckedplc.com )

MyHealthChecked PLC, based in Cardiff, is an AIM-quoted pioneering UK healthcare company focused on a range of at-home healthcare and wellness tests.

MyHealthChecked is the umbrella brand of a range of at-home DNA and RNA tests that have been developed following the acquisition of The Genome Store in November 2020. The tests are available online, and in some cases, for over-the-counter purchase.

The MyHealthChecked portfolio has been identified as part of a change in mindset as customers become more familiar with the concept of accessible healthcare in the growing at home testing kit market with a focus on accessibility at the right price, led by UK-based experts.

Notification and public disclosure of transactions by persons discharging managerial responsibilities ("PDMRs") and persons closely associated ("PCA") with them.

 

1

Details of the person discharging managerial responsibilities / person closely associated

a)

Name

Adam Reynolds

2

Reason for the notification

a)

Position/status

Non-Executive Chairman

b)

Initial notification /Amendment

Initial Notification

3

Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor

a)

Name

MYHEALTHCHECKED plc

b)

LEI

213800RBHY6LZDG13168

4

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

a)

 

Description of the financial instrument, type of instrument

Ordinary Shares



Identification code

ISIN: GB00BYZ2R301



b)

Nature of the transaction

Purchase of Ordinary Shares

c)

 

Price(s) and volume(s)






Price(s)

Volume(s)




1.7 pence

1,000,000






d)

 

Aggregated information




- Aggregated volume

N/A - Single Transaction



- Price




e)

Date of the transaction

3 August 2022

f)

Place of the transaction

London Stock Exchange - AIMX